SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 32.13-0.5%Nov 28 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: aknahow who wrote (16576)2/6/2004 10:40:28 AM
From: Bluegreen  Read Replies (1) of 17367
 
George, Xoma better be planning for BIG batches of Neuprex for acne NOW in case of a good results in Phase II and Phase III. If Phase II is a success the Phase III is planned by the end of the year! Don't forget also that IF the pediatric open heart study is a success then maybe will be able to add to the meningo. data for a resubmit? There are just so many things going on at Xoma not to mention Raptiva and its possible platform.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext